That said, I have been an investor (quite successfully) in the biotech industry. Players in that industry are incapable of forming a cartel...too much money involved.
I no longer invest in that industry because of the problems they face in pricing the solutions to the market (e.g. Gideon and its problems with Solvaldi/Harvoni...great product, but pricing problems kill its potential).
I am a poor nobody and have no clue about the world of investing and all that goes with it, so I bow to your knowledge in this regard. :-)
But costs of drugs are insanely high in the US, and POTUS Trump did mention that in the SOU address.